Advancements in Vaccine Research: Epidemiology, Immunogenicity, Effectiveness and Safety
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Efficacy and Safety".
Deadline for manuscript submissions: 20 March 2026 | Viewed by 337
Special Issue Editor
Interests: SARS-CoV-2; vaccines; natural infection; variant; immunity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccines are a cornerstone of public health, offering protection against infectious diseases and contributing to global health security. This Special Issue aims to provide a comprehensive overview of the latest advancements in vaccine epidemiology, immunogenicity, effectiveness and safety, fostering collaboration among researchers, healthcare professionals and policymakers. By bringing together diverse perspectives and studies, we seek to enhance our understanding of vaccine performance across different populations and settings, ultimately improving vaccination outcomes. We invite submissions that explore a range of themes, including but not limited to the following:
- Epidemiological Studies: Investigations into vaccine coverage, distribution and impact on disease incidence.
- Immunogenicity Assessments: Research on immune responses elicited by various vaccines in different demographics.
- Effectiveness Evaluations: Studies measuring real-world vaccine effectiveness and factors influencing outcomes.
- Safety Profiles: Evaluations of adverse events and long-term safety data associated with vaccines.
- Novel Vaccine Technologies: Innovations in vaccine development and delivery mechanisms.
- Policy and Implementation Research: Analysis of vaccination programs and strategies for increasing uptake.
Dr. Chloé Dimeglio
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine epidemiology
- immune response
- immunogenicity
- vaccine effectiveness
- safety
- infectious diseases
- public health
- vaccine development
- immunization strategies
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
